-
Je něco špatně v tomto záznamu ?
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy
J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT12288
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-04-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-04-01 do 2017-12-31
- MeSH
- lidé středního věku MeSH
- lidé MeSH
- longitudinální studie MeSH
- multisystémová atrofie komplikace MeSH
- Parkinsonova nemoc komplikace MeSH
- poruchy řeči klasifikace diagnóza etiologie MeSH
- progresivní supranukleární obrna komplikace MeSH
- retrospektivní studie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010550
- 003
- CZ-PrNML
- 005
- 20181018142212.0
- 007
- ta
- 008
- 160408s2015 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00415-015-7671-1 $2 doi
- 024 7_
- $a 10.1007/s00415-015-7671-1 $2 doi
- 035 __
- $a (PubMed)25683763
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Rusz, Jan $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 160 00, Prague 6, Czech Republic, rusz.mz@gmail.com. $7 xx0093732
- 245 10
- $a Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy / $c J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,
- 520 9_
- $a Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multisystémová atrofie $x komplikace $7 D019578
- 650 _2
- $a Parkinsonova nemoc $x komplikace $7 D010300
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a poruchy řeči $x klasifikace $x diagnóza $x etiologie $7 D013064
- 650 _2
- $a progresivní supranukleární obrna $x komplikace $7 D013494
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bonnet, Cecilia $7 xx0208282
- 700 1_
- $a Klempíř, Jiří $7 xx0081730
- 700 1_
- $a Tykalová, Tereza $7 _AN089882
- 700 1_
- $a Baborová, Eva $7 xx0192811
- 700 1_
- $a Novotný, Michal $7 ctu2018985794
- 700 1_
- $a Rulseh, Aaron Michael $7 xx0243723
- 700 1_
- $a Růžička, Evžen, $d 1957- $7 jo20000074065
- 773 0_
- $w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 262, č. 4 (2015), s. 992-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25683763 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20181018142712 $b ABA008
- 999 __
- $a ok $b bmc $g 1113979 $s 934918
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 262 $c 4 $d 992-1001 $e 20150217 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
- GRA __
- $a NT12288 $p MZ0
- LZP __
- $a Pubmed-20160408